Quality generics

Our core business is the development, production and distribution of high-quality, cost-effective generic medicines. Generics contain the same active substance as reference medicines and are therapeutically equivalent to the brand name versions. The only real difference is that they do not incur the same initial R&D costs, so they  can be sold for a lower price. As a global generics leader, Sandoz therefore helps to improve access to essential medicines worldwide.

Sandoz delivers high quality products that meet not only external regulatory requirements, but our own rigorous internal standards. Indeed, we produce far more than just standard generics. Our difficult-to-make products, including transdermal patches, inhalers and state-of-the-art  biosimilars, have few rivals in the industry. We also have an unrivalled position in the production of generic versions of essential anti-infective medicines (e.g. antibiotics).

Our decades of experience in developing and producing such medicines has enabled us to establish a pioneering position in many of the therapeutic areas of the future. Our global network of development and production sites plays a key role in helping us to maintain this leading position.